Anthropics Surprise Profit Projection Signals Competitive Edge Ahead of Potential IPO Foreign Investor Dollar Returns Plunge as Rupee Weakness and Sluggish Earnings Dent Nifty 50 Performance DraftKings Reports Q1 2026 Revenue of 165 Billion Up 17 YearOverYear Piper Sandler Highlights Potential Pressure on Tractor Supply Amid Weak Pet Spending Trends Trainline Raises FullYear Guidance for Second Time in 2025 US Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience VENU Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Operational Headwinds METC Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Rises Amid Strategic Updates CSV Q1 2026 Earnings EPS Beats Estimate Amid Tight Beat Stock Slips 2 TSAT Q1 2026 Earnings Massive EPS Miss Overshadows Missing Revenue as Stock Edges Higher UFCS Q1 2026 Earnings EPS Surges Past Estimates by 37 as Stock Declines Solana Company HSDT Holds Steady Near Support Eyes Key Resistance Cyclerion Therapeutics CYCN Edges Higher as Shares Test Key Resistance Levels Ebang International Holdings EBON Gains 245 as Shares Test Key Resistance Level AleAnna Inc ANNA Slips 467 as Stock Tests Key Support at 291 SKK Holdings Limited Slips Nearly 3 as Support Levels Come into Focus Trainline Raises FullYear Guidance for Second Time This Year TSAT Q1 2026 Earnings Massive EPS Miss Overshadows Missing Revenue as Stock Edges Higher UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093